ArticleClinicoEconomics and outcomes research : CEOR2019

Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland.

Timo Purmonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.